Oct 9, 2012
Date: Friday 19th October, 2012
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)
Title: Beyond the ‘Three B’s’(x2?)
Presented by Wayne Leech, Head of Centre for Innovation & Development, Bayer NZ
We know that Bayer Bought Bomac, but did that give the Bomac owners the Boat, the Bach and the BMW? And what has happened to Bomac? Our guest speaker for the October forum is Wayne Leech, Head of Centre for Innovation & Development, Bayer NZ and former CEO of Bomac. He will provide insight to the former three B’s – no promises about the latter – from his perspective of running a New Zealand company that is now an important element of a multinational corporate.
Bayer’s acquisition of Bomac in 2011 brought together two very different business cultures. It was also a striking example of the value of animal health to NZ’s bio industry. The acquisition process itself is of great interest. While Bomac was NZ’s largest privately owned animal healthcare company with 200 staff and 290 products being sold in over 60 countries, it was dwarfed by Bayer. Bayer was a multinational with over 108,000 staff, generating a revenue of 31.2 billion Euros. How was Bomac valued and what is its new role?
Please join us to hear Wayne Leech tell the Bomac to Bayer story and provide insight to the role and operation of this Bayer NZ company.
All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email email@example.com or phone (09) 373 7599 ext 89625 or 0274 305 758.